Adaptimmune Company
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Investors
%20.jpg)
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
Oxton, York, United Kingdom
Founded Date:
2008
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
$249.5M
Technology:
P4 Medicine
Employee Number:
51-100
Number Of Exists:
Post-IPO Equity
Estimated Revenue:
Less than $1M
Investors Number:
14
Industry:
Genomic and Epigenominc Instabillity